MedPath

A study of renal denervation in patients with refractory hypertensio

Not Applicable
Conditions
refractory essential hypertension
Registration Number
JPRN-UMIN000020835
Lead Sponsor
Osaka University Graduate School of Medicine, Cardiovascular medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
8
Inclusion Criteria

Not provided

Exclusion Criteria

1. renal artery stenosis of more than 25%, renal stent implnataion, dual renal arteries 2. eGFR <30mL/min/1,73m2 3. average systolic BP <135mmmHg by ABPM 4. myocardial infarction or coronary intervention within 6 months 5. diabetes requiring insulin (type 1 diabetes) 6. secondary hypertension 7. bleeding tendency or impairment of coagulation system 8. terminal illness with life expectancy less than 12 months 9. participating in other clinical trial 10. pregnancy 11. ineligible for the trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath